Cargando…
Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity
Cardiotoxicity remains a serious problem in anthracycline-treated oncologic patients. Therapeutic modulation of microRNA expression is emerging as a cardioprotective approach in several cardiovascular pathologies. MiR-34a increased in animals and patients exposed to anthracyclines and is involved in...
Autores principales: | Piegari, Elena, Cozzolino, Anna, Ciuffreda, Loreta Pia, Cappetta, Donato, De Angelis, Antonella, Urbanek, Konrad, Rossi, Francesco, Berrino, Liberato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378226/ https://www.ncbi.nlm.nih.gov/pubmed/32704131 http://dx.doi.org/10.1038/s41598-020-69038-3 |
Ejemplares similares
-
Doxorubicin cardiotoxicity and target cells: a broader perspective
por: De Angelis, Antonella, et al.
Publicado: (2016) -
MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat
por: Piegari, Elena, et al.
Publicado: (2016) -
Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension
por: Cappetta, Donato, et al.
Publicado: (2019) -
Lung Mesenchymal Stem Cells Ameliorate Elastase-Induced Damage in an Animal Model of Emphysema
por: Cappetta, Donato, et al.
Publicado: (2018) -
Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity
por: Cappetta, Donato, et al.
Publicado: (2017)